Full Text View
Tabular View
Study Results
Related Studies
Safety and Tolerability of Dabigatran Etexilate in Adolescents
This study has been completed.
Study NCT00844415   Information provided by Boehringer Ingelheim Pharmaceuticals

First Received on February 13, 2009.   Last Updated on April 10, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Venous Thromboembolism
Additional conditions recognized in this trial
Thromboembolism
Venous Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Thrombosis
Vascular Diseases
Interventions listed in this trial
dabigatran etexilate
Sponsors listed in this trial
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services